GLP-1s, injectable drugs that mimic hormones to reduce blood sugar and promote weight loss, have skyrocketed in popularity.

Ozempic users who suffer strokes appear to have much lower death rates and better long-term survival. Evidence points to a ...

Ozempic a brand name for semaglutide works by mimicking a natural hormone that helps your body regulate blood sugar reduce ...

With anti-obesity drugs like semaglutide set to drop in price from a staggering Rs 30,000 to just Rs 3,000 per month, ...

When researchers tested the amount of force exerted by mice, they found that some showed a decrease in strength, despite ...

Research suggests Ozempic may weaken muscles even when they don’t shrink, with most lean mass loss coming from organ size ...

Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...

Ozempic, the diabetes drug, induced drastic weight loss and reduced the risk of heart attacks in obese people. It became a ...

Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

A trial of a new daily pill for weight loss has shown that people taking the drug can shed kilos in weeks, potentially offering people with obesity a new and convenient alternative to jabs.

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...